Seoul National University Hospital

Seoul National University Hospital is the ultimate guardian of public health and the foundational cradle of Western medicine in South Korea. Tracing its lineage directly back to 1885 and the establishment of Jejungwon, the country’s first modern national hospital founded by royal decree of King Gojong, this revered academic powerhouse carries forward a century-old mission of benevolent medical practice that sets it completely apart from contemporary corporate-backed healthcare networks. It functions as the definitive national reference center, an elite public teaching citadel, and the official medical protectorate entrusted with the care of the President of South Korea. The physical evolution of the campus itself tells the story of modern Korean medical architecture; its historic 1978 structural overhaul marked a monumental shift from low-rise, horizontal medical pavilions to an ultra-efficient, fourteen-story vertical medical complex that forever transformed the capital's skyline and established a centralized, high-density model for public quaternary intervention. Unlike purely commercial entities, it serves as the ultimate public academic anchor, training the nation's elite medical minds and publishing approximately 3,800 breakthrough research papers in prominent international SCI journals every year. The clinical mastery achieved within this institutional fortress is driven by an unmatched legacy of global and national medical milestones that have rewritten the protocols of modern surgery and biotechnology. The facility serves as the birthplace of the globally acclaimed bilateral axillo-breast approach for thyroid cancer, a revolutionary minimally invasive robotic technique developed by its own faculty to eliminate visible neck scars and maximize patient recovery. This intellectual independence is reflected in clinical survival data that routinely outperforms premier Western institutions, featuring an exceptional 91. 9 percent breast cancer survival rate and a remarkable 86. 5 percent sphincter-preservation rate during complex colon cancer resections. As an unyielding engine of solid-organ and cellular innovation, the hospital performed South Korea's historic first successful liver transplant, pioneered infant lung transplant techniques, and introduced Korea's first successful production of hospital-generated CAR-T therapies. This relentless pursuit of clinical frontiers extends to cardiovascular science, where its teams executed the nation's first transcatheter pulmonary valve replacement using a next-generation, immunoreaction-free prosthetic heart valve, ensuring lifelong durability for patients with congenital heart defects. Significant successes in treating patients have been recorded in oncology in the form of a higher 5-year survival rate with breast and prostate cancer than in the USA and Europe.  In addition, gentle treatment methods allow 87% of patients with colorectal cancer to preserve the sphincter during surgery. The clinic also holds the record for removing malignant stomach tumors and has performed more than 20,000 operations. GammaKnife, which targets the centers of brain tumors, and ViewRay radiation therapy, controlled by real-time MRI, increase the effectiveness of tumor treatment in oncology by up to 90%. In particular, doctors have extensive experience in neuro-oncology and perform more than 1,800 interventions. In addition, the bronchoscopy center offers autofluorescence bronchoscopy and narrow-band bronchoscopy for the early diagnosis of lung cancer in high-risk groups. Pulmonologists also perform endobronchial ultrasound bronchoscopy, essential for diagnosing lung cancer.  Furthermore, urologists have considerable experience with Da Vinci robotic surgery to treat oncological and general surgical diseases.  Likewise, the clinic has the largest children's hospital in the country and the first neonatal intensive care unit in Korea. As a result, the pediatric department holds the record for successful heart surgery for a premature baby weighing 1 kg in Korea. The center for intensive treatment of childhood epilepsy has a leading role in the surgical treatment of patients with an incurable form. Architecturally and operationally, the Daehak-ro campus is organized as a beautifully synchronized quadripartite matrix comprising the main hospital, the independent children’s hospital, the organ-system-specific cancer facility, and the biomedical research institute. The children's hospital stands as a highly specialized sanctuary for fragile pediatric populations, operating unique subspecialty units, including a dedicated clinical genetics unit and a groundbreaking pediatric palliative medical clinic. This entire healthcare ecosystem is bound together by a legendary digital architecture; long before the global healthcare sector embraced deep automation, this facility became the absolute first hospital outside the United States to achieve the prestigious Class 7 medical informatization standard, having operated a fully integrated, paperless electronic medical record network since 2004 to eliminate diagnostic latency and human prescribing errors.